Jeffrey Del - Jun 24, 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role: Chief Commercial Officer
Signature: /s/ Jeffrey Del Carmen
Stock symbol: CPRX
Transactions as of: Jun 24, 2021
Transactions value $: $0
Form type: 4
Date filed: 6/25/2021, 04:25 PM
Next filing: Dec 30, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CPRX	Common stock, par value $0.001 per share	Options Exercise		+10K			10K	Jun 24, 2021	Direct	F1
transaction	CPRX	Common stock, par value $0.001 per share	Tax liability		-2.93K	-29.3%		7.07K	Jun 24, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CPRX	Restricted Stock Units	Options Exercise	$0	-10K	-2.11%	$0.00	463K	Jun 24, 2021	Common Stock	10K		Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
F2	Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3	Derivative securities vest in equal tranches, 1/3rd on June 23, 2021, 1/3rd on June 23, 2022, and 1/3rd on June 23, 2023.
F4	Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on June 24, 2021.